Dipeptidyl peptidase-IV in synovial fluid and in synovial fluid mononuclear cells of patients with rheumatoid arthritis

Clinica Chimica Acta

Volumn 411, Issue 1-16, 2010, Pages 1046-1050

  Sromova, Lucie ^a   Mareckova, Helena ^a   Sedova, Liliana ^b   Balaziova, Eva ^a   Sedo, Aleksi ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

Author keywords

Dipeptidyl peptidase; Rheumatoid arthritis; Stromal cell derived factor 1; Synovial fluid mononuclear cells

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; STROMAL CELL DERIVED FACTOR 1ALPHA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUOROMETRY; HUMAN; IMMUNODETECTION; IMMUNOPHENOTYPING; MALE; MONONUCLEAR CELL; NATURAL KILLER CELL; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ANIMALS; ANTIGENS, CD26; ARTHRITIS, RHEUMATOID; CELL MEMBRANE; FEMALE; GELATINASES; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MEMBRANE PROTEINS; MIDDLE AGED; OSTEOARTHRITIS; SERINE ENDOPEPTIDASES; SOLUBILITY; SYNOVIAL FLUID;

EID: 77953289030     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.03.034     Document Type: Article

References (27)

1. Sedo A., Duke-Cohan J.S., Balaziova E., Sedova L.R. Dipeptidyl peptidase IV activity and/or structure homologs: contributing factors in the pathogenesis of rheumatoid arthritis?. Arthritis Res Ther 2005, 7:253-269.
2. Sedo A., Malík R. Dipeptidyl peptidase IV-like molecules: homologous proteins or homologous activities?. Biochim Biophys Acta 2001, 1550:107-116.
3. Sedo A., Stremenova J., Busek P., Duke-Cohan J.S. Dipeptidyl peptidase-IV and related molecules: markers of malignancy?. Expert Opin Med Diagn 2008, 2:677-689.
4. Milner J.M., Patel A., Rowan A.D. Emerging roles of serine proteinases in tissue turnover in arthritis. Arthritis Rheum 2008, 58:3644-3656.
5. Wolf M., Albrecht S., Märki C. Proteolytic processing of chemokines: implications in physiological and pathological conditions. Int J Biochem Cell Biol 2008, 40:1185-1198.
6. Kim K.W., Cho M.L., Kim H.R., et al. Up-regulation of stromal cell-derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin-17 and CD40L-CD40 interaction. Arthritis Rheum 2007, 56:1076-1086.
7. Mavropoulos J.C., Cuchacovich M., Llanos C., et al. Anti-tumor necrosis factor-alpha therapy augments dipeptidyl peptidase IV activity and decreases autoantibodies to GRP78/BIP and phosphoglucose isomerase in patients with rheumatoid arthritis. J Rheumatol 2005, 2:2116-2124.
8. Cuchacovich M., Gatica H., Pizzo S.V., Gonzalez-Gronow M. Characterization of human serum dipeptidyl peptidase IV (CD26) and analysis of its autoantibodies in patients with rheumatoid arthritis and other autoimmune diseases. Clin Exp Rheumatol 2001, 19:673-680.
9. Muscat C., Bertotto A., Agea E., et al. Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients. Clin Exp Immunol 1994, 98:252-256.
10. Gerli R., Muscat C., Bertotto A., et al. CD26 surface molecule involvement in T cell activation and lymphokine synthesis in rheumatoid and other inflammatory synovitis. Clin Immunol Immunopathol 1996, 80:31-37.
11. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
12. Stremenova J., Krepela E., Mares V., et al. Expression and enzymatic activity of dipeptidyl peptidase-IV in human astrocytic tumours are associated with tumour grade. Int J Oncol 2007, 31:785-792.
13. Sedo A., Malík R., Krepela E. Dipeptidyl peptidase IV in C6 rat glioma cell line differentiation. Biol Chem 1998, 379:39-44.
14. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
15. Durinx C., Lambeir A.M., Bosmans E., et al. Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides. Eur J Biochem 2000, 267:5608-5613.
16. Lee K.N., Jackson K.W., Christiansen V.J., Lee C.S., Chun J.G., McKee P.A., et al. Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein. Blood 2006, 107:1397-1404.
17. Gotoh H., Hagihara M., Nagatsu T., Iwata H., Miura T. Activities of dipeptidyl peptidase II and dipeptidyl peptidase IV in synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Clin Chem 1989, 35:1016-1018.
18. Busso N., Wagtmann N., Herling C., et al. Circulating CD26 is negatively associated with inflammation in human and experimental arthritis. Am J Pathol 2005, 166:433-442.
19. Aertgeerts K., Levin I., Shi L., et al. Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha. J Biol Chem 2005, 280:19441-19444.
20. Balaziova E., Sedova L., Mares V., Vlasicova K., Sevcik J., Sedo A. Dipeptidyl peptidase-IV activity and/or structure homologs (DASH): contributing factors in the pathogenesis of rheumatic diseases?. Adv Exp Med Biol 2006, 575:169-174.
21. Ohnuma K., Inoue H., Uchiyama M., et al. T-cell activation via CD26 and caveolin-1 in rheumatoid synovium. Mod Rheumatol 2006, 16:3-13.
22. Morimoto C., Schlossman S.F. The structure and function of CD26 in the T-cell immune response. Immunol Rev 1998, 161:55-70.
23. Bauer S., Jendro M.C., Wadle A., et al. Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes. Arthritis Res Ther 2006, 8:R171.
24. Wei L., Sun X., Kanbe K., et al. Chondrocyte death induced by pathological concentration of chemokine stromal cell-derived factor-1. J Rheumatol 2006, 33:1818-1826.
25. Pablos J.L., Santiago B., Galindo M., et al. Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis. J Immunol 2003, 170:2147-2152.
26. Nanki T., Hayashida K., El-Gabalawy H.S., et al. Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. J Immunol 2000, 165:6590-6598.
27. Herrera C., Morimoto C., Blanco J., et al. Comodulation of CXCR4 and CD26 in human lymphocytes. J Biol Chem 2001, 276:19532-19539.